Aytu BioPharma, Inc.AYTUNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank73
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P73
Within normal range
vs 2Y Ago
-12.8x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM-27.52%-291.6%
2025-7.03%-425.8%
20242.16%+170.8%
2023-3.05%+89.5%
2022-28.92%+34.6%
2021-44.25%-0.2%
2020-44.18%+77.9%
2019-199.59%+52.1%
2018-416.75%+26.0%
2017-562.80%-